Pharmacology for the NCLEX: Learn Drug Classes, Not Drug Names

Why class-based learning is the only approach that scales

There are thousands of medications and perhaps forty classes that matter for the NCLEX. Students who try to memorise drugs individually run out of capacity long before they run out of drugs, and they cannot answer a question about a drug they have not met.

Class-based learning inverts the problem. If you know that beta blockers end in -olol, reduce heart rate and contractility, and require a pulse check before administration, you can answer a question about nebivolol whether or not you have heard of it.

The exam is built for this. It rarely tests obscure drugs; it tests whether you understand what a class does, what it does to a patient who should not have it, and what you assess before giving it.

The best academic structure does not decorate the clinical reasoning—it makes that reasoning visible.

The suffixes worth memorising

A small set of suffixes covers a disproportionate share of exam drugs. Beta blockers end in -olol. ACE inhibitors end in -pril. Angiotensin receptor blockers end in -sartan. Calcium channel blockers commonly end in -dipine. Statins end in -statin.

Proton pump inhibitors end in -prazole and histamine-2 blockers in -tidine. Benzodiazepines commonly end in -pam or -lam. Most antivirals end in -vir, most antifungals in -azole, and aminoglycoside antibiotics in -micin or -mycin.

Corticosteroids usually contain -sone or -olone. Loop diuretics are less regular, but furosemide, bumetanide and torsemide form a small enough group to learn directly. Spend an hour on this list and a large amount of pharmacology becomes inferable.

Cardiovascular drugs

Beta blockers slow heart rate and reduce contractility. Hold for bradycardia, check apical pulse for one full minute before giving, and never stop them abruptly because rebound hypertension and angina follow. They can mask the tachycardia of hypoglycaemia, which matters in diabetes.

ACE inhibitors and ARBs reduce afterload. The distinguishing adverse effect of ACE inhibitors is a dry persistent cough, and switching to an ARB is the usual response. Both risk hyperkalaemia and both are contraindicated in pregnancy. Angioedema is the emergency to recognise.

Digoxin increases contractility and slows conduction. Therapeutic range is 0.5 to 2.0 ng/mL, apical pulse is checked for a full minute and the dose held below 60 beats per minute in adults, and hypokalaemia potentiates toxicity. Yellow-green visual halos are the classic toxicity clue.

Anticoagulants and the monitoring pairs

Warfarin is monitored by prothrombin time and INR, therapeutic around 2 to 3 for most indications, and reversed with vitamin K. Dietary vitamin K should be kept consistent rather than avoided, which is the teaching point questions test.

Heparin is monitored by activated partial thromboplastin time at 1.5 to 2.5 times control and reversed with protamine sulphate. Low molecular weight heparins such as enoxaparin generally require no routine monitoring and are given subcutaneously without expelling the air bubble.

Heparin-induced thrombocytopenia is the adverse effect to recognise: a falling platelet count several days into therapy, paradoxically with thrombosis rather than bleeding. The action is to stop all heparin immediately.

Insulins and oral agents

Insulin questions almost always turn on onset and peak, because that is when hypoglycaemia occurs. Rapid-acting insulins such as lispro and aspart act within about 15 minutes and are given with food in front of the patient. Regular insulin acts in about 30 minutes to an hour.

Intermediate NPH peaks several hours after administration, which is when a mid-afternoon hypoglycaemic event in a morning-dosed patient comes from. Long-acting glargine and detemir are essentially peakless and are not mixed with other insulins in the same syringe.

When mixing regular and NPH, draw air into NPH, air into regular, then withdraw regular first and NPH second — clear before cloudy. Regular insulin is the only insulin given intravenously.

High-alert drugs and never-events

Some facts are worth memorising as absolutes because the exam treats them that way. Potassium chloride is never given by intravenous push. Concentrated electrolytes are always diluted. Vesicant chemotherapy requires patency checks and extravasation protocols.

Aminoglycosides are nephrotoxic and ototoxic; monitor creatinine and ask about hearing changes and tinnitus. Vancomycin infused too quickly causes the flushing reaction historically called red man syndrome, managed by slowing the infusion rather than stopping the drug.

For any high-alert medication, expect the question to be about the check you perform rather than the pharmacology itself. Independent double-checks, patency, rate and the specific laboratory value are where the marks sit.

A workable study method

For each class, write a five-line card: suffix or example drugs, what it does, the assessment before giving it, the adverse effect that would make you hold or stop, and the one teaching point. Five lines per class and forty classes is a manageable body of knowledge.

Then practise with questions rather than re-reading the cards. Pharmacology questions on the NCLEX are applied — a patient scenario, a value, an action — and recall practice does not rehearse that.

Pair this with the lab values guide, because a large share of pharmacology questions are really laboratory questions in disguise: potassium and digoxin, INR and warfarin, creatinine and aminoglycosides.